EARNINGS: GENinCode loss narrows; Billington sales and profit jump
29th Sep 2026 15:30
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 0.60p on 19-10-2026 at 17:55:06 |
|---|---|
| Change | -0.025p -4% |
| Buy | 0.65p |
| Sell | 0.55p |
| Last Trade: | Buy 79.00 at 0.6395p |
| Day's Volume: | 1,374,834 |
| Last Close: | 0.60p |
| Open: | 0.625p |
| ISIN: | GB00BL97B504 |
| Day's Range | 0.60p - 0.625p |
| 52wk Range: | 0.588p - 4.25p |
| Market Capitalisation: | £4.52m |
| VWAP: | 0.606785p |
| Shares in Issue: | 753.04m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Genincode (GENI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 79 | 0.6395p | Ordinary |
15:51:01 - 19-Oct-26 |
| Buy* | 101 | 0.6395p | Ordinary |
15:14:33 - 19-Oct-26 |
| Buy* | 101,693 | 0.625p | Ordinary |
10:42:13 - 19-Oct-26 |
| Sell* | 9,408 | 0.561p | Ordinary |
10:32:36 - 19-Oct-26 |
| Buy* | 3,076 | 0.64p | Ordinary |
08:47:12 - 19-Oct-26 |
| Buy* | 153 | 0.65p | SI Trade |
08:34:31 - 19-Oct-26 |
| Buy* | 294 | 0.65p | SI Trade |
08:34:31 - 19-Oct-26 |
| Sell* | 250,000 | 0.60p | Ordinary |
08:34:17 - 19-Oct-26 |
| Sell* | 250,000 | 0.606p | Ordinary |
08:33:50 - 19-Oct-26 |
| Sell* | 250,000 | 0.606p | Ordinary |
08:33:32 - 19-Oct-26 |
Genincode (GENI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Sep 2026 4:11 pm | RNS | Holding(s) in Company |
| 29th Sep 2026 7:00 am | RNS | Half-year Financial Report |
| 22nd Sep 2026 7:00 am | RNS | Notice of Results |
| 28th Aug 2026 7:00 am | RNS | CARDIO inCode-Score milestone clinical results |
| 1st Jul 2026 1:30 pm | RNS | Result of AGM |
| 11th Jun 2026 5:42 pm | RNS | Holding(s) in Company |
| 10th Jun 2026 4:53 pm | RNS | Holding(s) in Company |
| 8th Jun 2026 7:00 am | RNS | Final Results |
| 4th Jun 2026 6:02 pm | RNS | Holding(s) in Company |
| 3rd Jun 2026 11:03 am | RNS | Holding(s) in Company |